JP Morgan Chase
NVO

JP Morgan Chase’s Novo Nordisk NVO Stock Holding History

JP Morgan Chase’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8M Buy
740,200
+494,100
+201% +$21.2M ﹤0.01% 1733
2026
Q1 		$8.68M Sell
246,100
-424,800
-63% -$20.1M ﹤0.01% 2813
2025
Q4 		$34.1M Sell
670,900
-111,300
-14% -$5.69M ﹤0.01% 1626
2025
Q3 		$43.4M Buy
782,200
+733,200
+1,496% +$42.9M ﹤0.01% 1502
2025
Q2 		$3.38M Sell
49,000
-461,000
-90% -$31.4M ﹤0.01% 3503
2025
Q1 		$35.4M Buy
510,000
+127,900
+33% +$10.6M ﹤0.01% 1513
2024
Q4 		$32.9M Buy
382,100
+319,100
+507% +$34.5M ﹤0.01% 1595
2024
Q3 		$7.5M Buy
63,000
+49,000
+350% +$6.53M ﹤0.01% 2871
2024
Q2 		$2M Buy
+14,000
New +$1.86M ﹤0.01% 3793
2023
Q4 		– Sell
-4,700
Closed -$427K – 7766
2023
Q3 		$427K Sell
4,700
-44,900
-91% -$3.96M ﹤0.01% 4572
2023
Q2 		$4.01M Buy
+49,600
New +$4.05M ﹤0.01% 3042
2018
Q2 		– Sell
-113,800
Closed -$2.8M – 5642
2018
Q1 		$2.8M Buy
+113,800
New +$2.99M ﹤0.01% 3034

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase's NVO Position: Q2 2026 in Review

JP Morgan Chase reduced its Novo Nordisk (NVO) stake by 43% in Q2 2026, selling an estimated $51.4M and leaving 1,612,426 shares worth $77.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

JP Morgan Chase first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $722M in Q1 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • JP Morgan Chase held 1,612,426 shares of Novo Nordisk worth $77.9M as of Q2 2026.
  • JP Morgan Chase sold 1,196,392 Novo Nordisk shares in Q2 2026, an estimated $51.4M.
  • Novo Nordisk made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1193 holding.
  • JP Morgan Chase first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Novo Nordisk position peaked at $722M in Q1 2024.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.